Cargando…

Performance of BinaxNOW G6PD Deficiency Point-of-Care Diagnostic in P. vivax-Infected Subjects

Accurate diagnosis of glucose-6-phosphate dehydrogenase (G6PD) deficiency is required to avoid the risk of acute hemolysis associated with 8-aminoquinoline treatment. The performance of the BinaxNOW G6PD test compared with the quantitative spectrophotometric analysis of G6PD activity was assessed in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Osorio, Lyda, Carter, Nick, Arthur, Preetam, Bancone, Germana, Gopalan, Sowmya, Gupta, Sandeep K., Noedl, Harald, Kochar, Sanjay K., Kochar, Dhanpat K., Krudsood, Srivicha, Lacerda, Marcus V., Llanos-Cuentas, Alejandro, Rueangweerayut, Ronnatrai, Srinivasan, Ramadurai, Treiber, Moritz, Möhrle, Jörg J., Green, Justin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The American Society of Tropical Medicine and Hygiene 2015
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4347383/ https://www.ncbi.nlm.nih.gov/pubmed/25385861 http://dx.doi.org/10.4269/ajtmh.14-0298

Ejemplares similares

Accuracy of Expired BinaxNOW Rapid Antigen Tests
por: Vaeth, Mary Jane E., et al.
Publicado: (2023)

Estimation of the Antirelapse Efficacy of Tafenoquine, Using Plasmodium vivax Genotyping
por: Beck, Hans-Peter, et al.
Publicado: (2016)

The BinaxNOW pneumococcal antigen test: An adjunct for diagnosis of pneumococcal bacteraemia
por: Tootla, Hafsah D., et al.
Publicado: (2021)

Analytical Sensitivity of the Abbott BinaxNOW COVID-19 Ag Card
por: Perchetti, Garrett A., et al.
Publicado: (2021)

Tafenoquine treatment of Plasmodium vivax malaria: suggestive evidence that CYP2D6 reduced metabolism is not associated with relapse in the Phase 2b DETECTIVE trial
por: St Jean, Pamela L., et al.
Publicado: (2016)

Diagnostic value of BinaxNOW antigen card for Severe Acute Respiratory Syndrome Coronavirus 2
por: Mai, Yue-Xue, et al.
Publicado: (2023)

Comparison of Sofia Legionella FIA and BinaxNOW® Legionella urinary antigen card in two national reference centers
por: Beraud, L., et al.
Publicado: (2015)

Detection of the Omicron Variant Virus With the Abbott BinaxNow SARS-CoV-2 Rapid Antigen Assay
por: Regan, James, et al.
Publicado: (2022)

Comparison of the ImmuView and the BinaxNOW antigen tests in detection of Streptococcus pneumoniae and Legionella pneumophila in urine
por: Athlin, S., et al.
Publicado: (2017)

Performance Characteristics of BinaxNOW COVID-19 Antigen Card for Screening Asymptomatic Individuals in a University Setting
por: Okoye, Nkemakonam C., et al.
Publicado: (2021)

Evaluation of the BinaxNOW COVID-19 Rapid Antigen Test in an Asymptomatic Patient Population Undergoing Preprocedural Screening
por: Stokes, Nadarra L., et al.
Publicado: (2021)

Plasmodium vivax Malaria
por: Kochar, Dhanpat K., et al.
Publicado: (2005)

Assessment of the Abbott BinaxNOW SARS-CoV-2 rapid antigen test against viral variants of concern
por: Rao, Anuradha, et al.
Publicado: (2022)

High Sensitivity and NPV for BinaxNOW Rapid Antigen Test in Children at a Mass Testing Site during Prevalent Delta Variant Period
por: Sun, Kristie J., et al.
Publicado: (2022)

Comparison of a Prototype SARS-CoV-2 Lateral Flow IMMUNOASSAY with the BinaxNOW(TM) COVID-19 Antigen CARD
por: Hill, Haydon J., et al.
Publicado: (2022)

Implementation and Accuracy of BinaxNOW Rapid Antigen COVID-19 Test in Asymptomatic and Symptomatic Populations in a High-Volume Self-Referred Testing Site
por: Siddiqui, Zishan K., et al.
Publicado: (2021)

Evaluation of the Abbott BinaxNOW rapid antigen test for SARS-CoV-2 infection in children: Implications for screening in a school setting
por: Sood, Neeraj, et al.
Publicado: (2021)

Comparison of BinaxNOW and SARS-CoV-2 qRT-PCR Detection of the Omicron Variant from Matched Anterior Nares Swabs
por: Landaverde, Lena, et al.
Publicado: (2022)

Multidisciplinary assessment of the Abbott BinaxNOW SARS-CoV-2 point-of-care antigen test in the context of emerging viral variants and self-administration
por: Frediani, Jennifer K., et al.
Publicado: (2021)

Cannabinoid hyperemesis syndrome as an unusual cause of cyclic vomiting
por: Ramadurai, Srinivasan, et al.
Publicado: (2016)

Effectiveness of Abbott BinaxNOW Rapid Antigen Test for Detection of SARS-CoV-2 Infections in Outbreak among Horse Racetrack Workers, California, USA
por: Surasi, Krishna, et al.
Publicado: (2021)

SARS-CoV-2 molecular testing and whole genome sequencing following RNA recovery from used BinaxNOW COVID-19 antigen self tests
por: Nguyen, Phuong-Vi, et al.
Publicado: (2023)

Field assessment of BinaxNOW antigen tests as COVID-19 treatment entry point at a community testing site in San Francisco during evolving omicron surges
por: Schrom, John, et al.
Publicado: (2023)

366. Abbott BinaxNOW Rapid Antigen Test Performance in Detecting SARS-CoV-2 Infections in a COVID-19 Outbreak Among Horse Racetrack Workers
por: Surasi, Krishna, et al.
Publicado: (2021)

Evaluation of Abbott BinaxNOW Rapid Antigen Test for SARS-CoV-2 Infection at Two Community-Based Testing Sites — Pima County, Arizona, November 3–17, 2020
por: Prince-Guerra, Jessica L., et al.
Publicado: (2021)

Characterization of Plasmodium vivax-associated admissions to reference hospitals in Brazil and India
por: Siqueira, André M, et al.
Publicado: (2015)

Association between erectile dysfunction and cardiovascular risk in individuals with type-2 diabetes without overt cardiovascular disease
por: Meena, Babu Lal, et al.
Publicado: (2009)

Performance of the ImmuView and BinaxNOW assays for the detection of urine and cerebrospinal fluid Streptococcus pneumoniae and Legionella pneumophila serogroup 1 antigen in patients with Legionnaires’ disease or pneumococcal pneumonia and meningitis
por: Edelstein, Paul H., et al.
Publicado: (2020)

Performance Characteristics of the Abbott BinaxNOW SARS-CoV-2 Antigen Test in Comparison to Real-Time Reverse Transcriptase PCR and Viral Culture in Community Testing Sites during November 2020
por: Almendares, Olivia, et al.
Publicado: (2022)

Evaluation of the Abbott BinaxNOW COVID-19 Test Ag Card for rapid detection of SARS-CoV-2 infection by a local public health district with a rural population
por: Pollreis, Rachel E., et al.
Publicado: (2021)

Clinical Proteomics of the Neglected Human Malarial Parasite Plasmodium vivax
por: Acharya, Pragyan, et al.
Publicado: (2011)

Dataset of natural antisense transcripts in P. vivax clinical isolates derived using custom designed strand-specific microarray
por: Boopathi, P.A., et al.
Publicado: (2014)

Hemolytic Potential of Tafenoquine in Female Volunteers Heterozygous for Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency (G6PD Mahidol Variant) versus G6PD-Normal Volunteers
por: Rueangweerayut, Ronnatrai, et al.
Publicado: (2017)

Field Performance and Public Health Response Using the BinaxNOW(TM) Rapid Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antigen Detection Assay During Community-Based Testing
por: Pilarowski, Genay, et al.
Publicado: (2020)

Reduction of Sphingosine Kinase 1 Phosphorylation and Activity in Plasmodium-Infected Erythrocytes
por: Sah, Raj Kumar, et al.
Publicado: (2020)

A cross strain Plasmodium falciparum microarray optimized for the transcriptome analysis of Plasmodium falciparum patient derived isolates
por: Subudhi, Amit Kumar, et al.
Publicado: (2016)

Diagnostic utility of BINAX NOW RSV – an evaluation of the diagnostic performance of BINAX NOW RSV in comparison with cell culture and direct immunofluorescence
por: Jonathan, Nteimam
Publicado: (2006)

The clinical efficacy of artemether/lumefantrine (Coartem(®))
por: Makanga, Michael, et al.
Publicado: (2009)

Pharmacogenetic assessment of tafenoquine efficacy in patients with Plasmodium vivax malaria
por: St Jean, Pamela L., et al.
Publicado: (2020)

A randomized, double-blind, active-control trial to evaluate the efficacy and safety of a three day course of tafenoquine monotherapy for the treatment of Plasmodium vivax malaria
por: Fukuda, Mark M., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_o7aotjl0jf8ubbki4pr88u058p